Depression Treatment Market Analysis By Industry Share, Merger, Acquisition, Size Estimation, New Investment Opportunities, Statistics, Overview, and Forec
Search jobs 11-Jan-2021 Takeda Provides Pipeline Update and Shares Goal to Increase Revenue 50% by FY2030 at the 39th Annual J.P. Morgan Healthcare Conference
−
1, Representing 50% Growth from FY2019
−
Wave 1 Pipeline Portfolio Includes 12 New Molecular Entities Targeted for Launch by FY2024 Representing Best-in-Class/First-in-Class Therapies with Significant Market Potential
−
Rapid Deleveraging On Track to Achieve Target of 2x Net Debt / adjusted EBITDA within Fiscal Years 2021 to 2023
OSAKA, Japan & CAMBRIDGE, Mass. (BUSINESS WIRE) Takeda Pharmaceutical Company Limited
(TSE:4502/NYSE:TAK) (“Takeda”) provided an update on the progress of its continued transformation and growth today at the virtual 39th Annual J.P. Morgan Healthcare Conference. President and Chief Executive Officer, Christophe Weber, shared details on Takeda’s portfolio and pipeline strategy and financial outlook, including key programs expected
Neuraxpharm launches first product in Japan
- First buccal midazolam to receive approval in Japan, world s second largest central nervous system market
[1]
DÜSSELDORF, Germany and BARCELONA, Spain, Jan. 12, 2021 /PRNewswire/
Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the central nervous system (CNS), today announces the launch in Japan of the recently acquired prescription brand Buccolam (oromucosal midazolam) following its approval as the first buccally administered formulation for the treatment of
status epilepticus (SE) in the country.
The launch follows the completion of Neuraxpharm s acquisition of Buccolam from Takeda Pharmaceutical Company Limited (Takeda) in September and represents the expansion of Neuraxpharm s footprint outside Europe into Japan, the third largest pharmaceutical market in the world
Redirecting to Takeda to Present at The 39th Annual J P Morgan Healthcare Conference q8dailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from q8dailynews.com Daily Mail and Mail on Sunday newspapers.